GGrantIndex
← Search

Developmental Funds

$417,200P30FY2025CANIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

Developmental Funds Developmental Funds (DFs) add significant value to the USC Norris Comprehensive Cancer Center (NCCC) members who conduct basic, translational, clinical, and population research. Specifically, we utilized CCSG DFs in the current grant period to recruit 11 new faculty members, to support seven CCSG pilot projects, and to catalyze a restructuring of our bioinformatics platform, leading to the expansion of the NCCC Biostatistics Core into a full-service Data Science Shared Resource (SR). Notably, DFs were utilized, in part, to support the cluster recruitment of John Carpten PhD and colleagues from the Translational Genomics Research Institute (TGen) who competed successfully for several new grants including a new NCI U54 CaRE2 center grant on unique communities which integrates faculty across all five NCCC Programs. CCSG DFs were augmented by substantial institutional investments to foster high impact collaborative research with emphasis on addressing cancer burdens and disparities in our catchment area. The return on investment (ROI) for CCSG DFs in the current period is 21:1 and contributed to the increase in NCI funding by 22%, peer-reviewed funding by 11%, and overall cancer related funding by 18% (direct costs). The process for awarding DFs is led by Administration with final decisions made by the NCCC Director with input from Senior and Program Leaders. There are notable improvements in this process during the current grant period. First, based on the NCCC Strategic Plan, targeted areas for DF-supported faculty recruitments are identified by the Executive Committee and faculty are recruited through a systematic search process. Second, the new Director refreshed the Scientific Review Committee for DF-supported pilot projects; this committee reviews and scores all applications for internally-funded pilot award opportunities. Further, the new Associate Director for Administration enhanced the pilot awards process, from the distribution of RFAs, to review and decision-making, and finally to the tracking of metrics of success for DF-supported members. Tracking of metrics of success for faculty recruits and pilot grants has been enhanced substantially through the recruitment of a seasoned research administrator. In this application, we request ($1,375,000) to support strategic faculty recruitments ($1M) and developmental pilot projects ($375K), to be supplemented by institutional investments, as we did in the current project period. The new NCCC Strategic Plan, “Shaping the Future of Cancer Science 2020-2025”, will guide these future investments, with a focus on specific priorities: interventions to reduce cancer disparities, cancer therapeutics/drug and biomarker development, and translational and clinical research in immune-oncology. As in the current period, we will maintain a sharp focus on recruiting the best and brightest faculty in medicine.

View original record on NIH RePORTER →